Arcus Biosciences, Inc.
RCUS
$31.00
$0.752.48%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/27/2026
-
Tickeron - Stocks
6/25/2026
-
TipRanks
6/24/2026
-
The Cerbat Gem
6/24/2026
-
The Cerbat Gem
6/24/2026
-
Business Wire
6/24/2026
-
The Cerbat Gem
6/24/2026
-
The Cerbat Gem
6/24/2026
-
MarketBeat
6/24/2026
-
Tickeron - Stocks
6/23/2026
-
Tickeron - Stocks
6/23/2026
-
Tickeron - Stocks
6/18/2026
-
Tickeron - Stocks
6/17/2026
-
Tickeron - Stocks
6/16/2026
-
Simply Wall St
6/16/2026
-
MarketBeat
6/16/2026
-
Tickeron - Stocks
6/14/2026
-
MarketBeat
6/14/2026
-
MarketBeat
6/12/2026
-
TipRanks
6/11/2026
-
Simply Wall St
6/11/2026
-
TipRanks
6/10/2026
-
TipRanks
Camzyos Priority Review And New Oncology Data Could Be A Game Changer For Bristol-Myers Squibb (BMY)
6/10/2026
-
Simply Wall St
6/10/2026
-
SeekingAlpha
6/10/2026
-
Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 5, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 694 6200
Address
3928 Point Eden Way
Hayward, CA 94545
Hayward, CA 94545
Country
Year Founded
Business Description
Sector
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes...
more